In 57 gastric GISTs, Tβ4 expression was directly correlated with higher risk groups, and this held in multivariate analysis.
In plain wordsIn gastric tumors, higher levels of the body's own thymosin beta‑4 were linked to higher-risk tumor groups.
- Peptide
- Thymosin beta-4 (human)
- Outcome
- IncreaseTβ4 expression and tumor risk group
- Study
n = 57
- Outcome group
- Tumor growth · Cancer
Source sentences
Tβ4 expression was found to be directly corrrelated with higher risk groups, tumor size, mitotic count, cellularity, and necrosis while it was inversely correlated with overall survival (OS) by univariate analysis (p=0.000, p=0.001, p=0.000, p=0.025, p=0.023, and p=0.042, respectively).
2 context sentences(design, population, supporting numbers)
The direct association between Tβ4 expression and risk groups were also supported by multivariate analysis (p=0.000, β=0.497, t=4.374).
Tβ4 antibody was applied to the 4μm-thick paraffin sections of 57 gastric GISTs by immunohistochemistry.
This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.